[HTML][HTML] Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell …
Journal of clinical oncology, 2011•ncbi.nlm.nih.gov
Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow
Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid
Leukemia - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List J Clin Oncol PMC3083874 Other
Formats PDF (137K) Actions Cite Collections Share Permalink Copy RESOURCES Similar …
Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid
Leukemia - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List J Clin Oncol PMC3083874 Other
Formats PDF (137K) Actions Cite Collections Share Permalink Copy RESOURCES Similar …
Abstract
Purpose
Allogeneic hematopoietic cell transplantation (HCT) benefits many patients with acute myeloid leukemia (AML) in first remission. Hitherto, little attention has been given to the prognostic impact of pretransplantation minimal residual disease (MRD).
ncbi.nlm.nih.gov